A computer model and program for xenobiotic disposition during pregnancy.

A physiologically based pharmacokinetic computer model and program have been developed that depict internal disposition of chemicals during pregnancy in the mother and embryo/fetus. The model is based on human physiology but has been extended to simulate laboratory animal data. The model represents the distribution, metabolism, and elimination of two chemicals in both the maternal and embryo/fetal systems; the program handles the two chemicals completely independently or interactively with the two chemicals sharing routes of metabolism and/or elimination. The FORTRAN program computes the concentration of the two chemicals in 26 organs/tissues in the pregnant mother and 15 organs/tissues in the embryo/fetus using a 486DX4 or Pentium PC. Adjustments for embryo/fetal organ and tissue volumes as a function of developmental age are made utilizing the Gompertz growth equation for the developing embryo/fetus and allometric relationships for the developing organs. Various changes in the maternal compartments which could affect the distribution of a xenobiotic during pregnancy are also included in the model. Input files require estimates of binding coefficients, first- and/or second-order metabolism constants, level of interaction between the two chemicals, and dosing information. Different possible routes of administration are included (e.g., i.v., infusion, oral, dermal, and inhalation, as well as repeated doses or exposures). Regression analysis can be conducted on any combination of these various parameters to fit actual data. Output concentration-time curves are available simultaneously from all 82 differential equations. An illustrative example compares observed data with simulations for imipramine and its demethylated metabolite, desipramine, in both the maternal rat and her fetuses. Methyl mercury data for the non-pregnant and pregnant rat also are compared with human data. Based on parameters determined from analysis of rat data, the model is readjusted for human physiology and predicts human maternal and fetal tissue concentrations as a function of time.

[1]  John F. Young,et al.  Physiological "constants" for PBPK models for pregnancy. , 1997, Journal of toxicology and environmental health.

[2]  R B Conolly,et al.  Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. , 1995, Toxicology and applied pharmacology.

[3]  John F. Young,et al.  A physiologically based pharmacokinetic computer model for human pregnancy. , 1994, Teratology.

[4]  P. Allen,et al.  The kinetics of intravenously administered methyl mercury in man. , 1994, Toxicology and applied pharmacology.

[5]  R. Luecke,et al.  Mathematical representation of organ growth in the human embryo/fetus. , 1995, International journal of bio-medical computing.

[6]  D Krewski,et al.  Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models. , 1995, Journal of biopharmaceutical statistics.

[7]  J. Nielsen,et al.  Methylmercury: significance of intrauterine and postnatal exposures. , 1994, Clinical chemistry.

[8]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[9]  W. Wosilait.  5 – Displacement Interactions Resulting from Competition for Binding Sites on Proteins , 1990 .

[10]  J E Simmons,et al.  Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats. , 1994, Toxicology and applied pharmacology.

[11]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.

[12]  J C Lewis,et al.  Microcomputer program for interactions in drug elimination in the rat. , 1988, Computer methods and programs in biomedicine.

[13]  D Newton,et al.  Elevation of Mercury in Human Blood from Controlled Chronic Ingestion of Methylmercury in Fish , 1984, Human toxicology.

[14]  S Skerfving,et al.  Methylmercury exposure, mercury levels in blood and hair, and health status in Swedes consuming contaminated fish. , 1974, Toxicology.

[15]  Devane Cl.  Pharmacokinetic correlates of fetal drug exposure. , 1991 .

[16]  P. Allen,et al.  Physiological model for the pharmacokinetics of methyl mercury in the growing rat. , 1993, Toxicology and applied pharmacology.

[17]  J. Aaseth,et al.  The effect of N-acetylated DL-penicillamine and DL-homocysteine thiolactone on the mercury distribution in adult rats, rat foetuses and macaca monkeys after exposure to methyl mercuric chloride. , 2009, Acta pharmacologica et toxicologica.

[18]  Mark A. Kramer,et al.  The simultaneous solution and sensitivity analysis of systems described by ordinary differential equations , 1988, TOMS.

[19]  J. Simpkins,et al.  Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[20]  R. Luecke,et al.  Physiological flow model for drug elimination interactions in the rat. , 1980, Computer Programs in Biomedicine.

[21]  M. Kilbey,et al.  Methodological issues in controlled studies on effects of prenatal exposure to drug abuse. , 1991, NIDA research monograph.

[22]  R. Luecke,et al.  A mathematical analysis of human embryonic and fetal growth data. , 1992, Growth, development, and aging : GDA.

[23]  Yucai Zhu,et al.  Identification of Multivariable Industrial Processes , 1993 .

[24]  R B Conolly,et al.  Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model. , 1993, Toxicology and applied pharmacology.

[25]  H J Clewell,et al.  Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[26]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[27]  E J O'Flaherty,et al.  A physiologically based kinetic model of rat and mouse gestation: disposition of a weak acid. , 1992, Toxicology and applied pharmacology.